Related Experiment Video
Updated: Jun 19, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Advances in paracoccidioidomycosis
M Ameen1, C Talhari, S Talhari
1St. John's Institute of Dermatology, Guy's and St Thomas' NHS Trust, London SE1 7EH, UK. mahreenameen@hotmail.com
Abstract:
Paracoccidioidomycosis is the most prevalent systemic mycosis in Latin America. It is becoming globally relevant, as increasing numbers of cases have been detected in returning travellers and immigrants from endemic regions. It is characterized by pulmonary involvement, lymphadenopathy, and chronic progression of mucocutaneous lesions. Untreated, systemic disease can be severe and fatal. Skin features are common and characteristic, enabling the dermatologist to diagnose infection early and prevent the development of serious sequelae. This review outlines the clinical features and management of paracoccidioidomycosis and discusses notable recent developments in molecular diagnosis, prognostics and therapies.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Candidiasis
Leishmaniasis
Antiprotozoal Agents